Structures by: Motherwell W. D.

Total: 80

2

C13H18N4O10

Karki, ShyamFriščić, TomislavJones, WilliamMotherwell, W. D. Samuel

Molecular Pharmaceutics (2007) 4, 3 347

a=17.9217(2)Å   b=6.17660(10)Å   c=15.3751(3)Å

α=90.00°   β=105.2120(10)°   γ=90.00°

3

(C8H10N4O2),(C6H8O7)

Karki, ShyamFriščić, TomislavJones, WilliamMotherwell, W. D. Samuel

Molecular Pharmaceutics (2007) 4, 3 347

a=7.38740(10)Å   b=8.3967(2)Å   c=13.5053(3)Å

α=91.3330(10)°   β=99.0400(10)°   γ=99.5880(10)°

C14H25ClN2

C14H25ClN2

Attfield, J.Cole, J.C.Cox, P.J.Maginn, S.J.Motherwell, W.D.S.Nowell, H.Shankland, K.

New Journal of Chemistry (2002)

a=7.40022(11)Å   b=8.56690(15)Å   c=13.69231(32)Å

α=106.2107(14)°   β=90.8532(11)°   γ=98.7783(12)°

2,3 lutidine pamoate

2(C7H10N),C23H14O6

Haynes, Delia A.Weng, Ze F.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2009) 11, 2 254-260

a=15.197(3)Å   b=13.262(3)Å   c=15.716(3)Å

α=90.00°   β=107.20(3)°   γ=90.00°

2,4 lutidine pamoate

C23H14O6,2(C7H10N)

Haynes, Delia A.Weng, Ze F.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2009) 11, 2 254-260

a=8.2989(17)Å   b=11.453(2)Å   c=16.924(3)Å

α=72.76(3)°   β=85.65(3)°   γ=77.85(3)°

3,4 lutidine pamoate

C23H14O6,2(C7H10N)

Haynes, Delia A.Weng, Ze F.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2009) 11, 2 254-260

a=11.196(2)Å   b=12.653(3)Å   c=22.963(5)Å

α=104.32(3)°   β=103.24(3)°   γ=91.58(3)°

2,6 lutidine succinic acid co-crystal

2(C7H9N),C4H6O4

Haynes, Delia A.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 11 830

a=15.733(3)Å   b=15.106(3)Å   c=7.6047(15)Å

α=90.00°   β=98.56(3)°   γ=90.00°

2,3 lutidine fumarate

C7H10N,C4H3O4,C4H4O4

Haynes, Delia A.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 11 830

a=9.0541(18)Å   b=18.159(4)Å   c=9.7343(19)Å

α=90.00°   β=91.20(3)°   γ=90.00°

2,3 lutidine fumaric acid co-crystal

C14H18N2,C4H4O4

Haynes, Delia A.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 11 830

a=9.8746(4)Å   b=7.1925(4)Å   c=12.2559(5)Å

α=90.00°   β=96.810(3)°   γ=90.00°

2,4 lutidine fumarate

C7H10N1,0.5(C4H2O41),0.5(C4H4O4)

Haynes, Delia A.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 11 830

a=3.96530(10)Å   b=13.7652(4)Å   c=20.0488(6)Å

α=90.00°   β=91.6030(10)°   γ=90.00°

2,3 lutidine succinic acid co-crystal

2(C7H9N),C4H6O4

Haynes, Delia A.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 11 830

a=10.0598(3)Å   b=7.3023(3)Å   c=12.2512(4)Å

α=90.00°   β=97.470(2)°   γ=90.00°

2,4 lutidine succinic acid co-crystal

2(C7H9N),C4H6O4

Haynes, Delia A.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 11 830

a=4.8672(10)Å   b=12.763(3)Å   c=14.374(3)Å

α=90.00°   β=96.20(3)°   γ=90.00°

2,5 lutidine fumarate

C7H10N1,C4H4O4,0.5(C4H2O42)

Haynes, Delia A.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 11 830

a=7.2696(2)Å   b=9.1353(3)Å   c=11.6311(3)Å

α=84.115(2)°   β=72.513(2)°   γ=88.763(2)°

2,5 lutidine succinic acid co-crystal

2(C7H9N),C4H6O4

Haynes, Delia A.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 11 830

a=4.7197(9)Å   b=15.272(3)Å   c=12.819(3)Å

α=90.00°   β=97.38(3)°   γ=90.00°

3,4 lutidine fumarate

C7H10N1,0.5(C4H2O42),C4H4O4

Haynes, Delia A.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 11 830

a=7.0478(2)Å   b=10.0870(3)Å   c=10.8570(3)Å

α=102.305(2)°   β=104.584(2)°   γ=107.975(2)°

3,4 lutidine succinic acid co-crystal

2(C7H9N),C4H6O4

Haynes, Delia A.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 11 830

a=9.802(2)Å   b=6.0385(12)Å   c=15.626(3)Å

α=90.00°   β=102.49(3)°   γ=90.00°

3,5 lutidine fumaric acid co-crystal

2(C7H9N),C4H4O4

Haynes, Delia A.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 11 830

a=8.2345(16)Å   b=16.299(3)Å   c=6.9681(14)Å

α=90.00°   β=108.17(3)°   γ=90.00°

3,5 lutidine succinic acid co-crystal

2(C7H9N),C4H6O4

Haynes, Delia A.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 11 830

a=10.464(2)Å   b=4.9696(10)Å   c=17.113(3)Å

α=90.00°   β=95.67(3)°   γ=90.00°

C8H7ClNO3

C8H7ClNO3

Edwards, M. R.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 7 545

a=3.7440(10)Å   b=6.0320(10)Å   c=18.631(2)Å

α=97.660(10)°   β=92.280(10)°   γ=90.470(10)°

C24H30Cl2N2O6

C24H30Cl2N2O6

Edwards, M. R.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 7 545

a=5.0843(3)Å   b=8.3131(5)Å   c=15.9637(8)Å

α=77.760(3)°   β=89.771(3)°   γ=74.353(3)°

C18H20N2O6

C18H20N2O6

Edwards, M. R.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 7 545

a=9.2224(4)Å   b=10.0926(5)Å   c=10.0772(5)Å

α=90.00°   β=113.116(3)°   γ=90.00°

C26H36N2O6

C26H36N2O6

Edwards, M. R.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2006) 8, 7 545

a=36.856(2)Å   b=5.1674(2)Å   c=29.4327(18)Å

α=90.00°   β=112.806(2)°   γ=90.00°

C8H10N4O2,C5H8O4

C8H10N4O2,C5H8O4

Trask, Andrew VMotherwell, W D SamuelJones, William

Chemical communications (Cambridge, England) (2004) 7 890-891

a=13.0129(5)Å   b=6.6017(2)Å   c=17.1427(8)Å

α=90.00°   β=97.8360(10)°   γ=90.00°

C8H10N4O2,C5H8O4

C8H10N4O2,C5H8O4

Trask, Andrew VMotherwell, W D SamuelJones, William

Chemical communications (Cambridge, England) (2004) 7 890-891

a=8.3212(8)Å   b=8.6667(8)Å   c=11.3636(12)Å

α=68.955(4)°   β=78.559(4)°   γ=74.236(4)°

2,3 lutidine pamoate

2(C7H10N),C23H14O6

Haynes, Delia A.Weng, Ze F.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2009) 11, 2 254-260

a=15.197(3)Å   b=13.262(3)Å   c=15.716(3)Å

α=90.00°   β=107.20(3)°   γ=90.00°

3,4 lutidine pamoate

C23H14O6,2(C7H10N)

Haynes, Delia A.Weng, Ze F.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2009) 11, 2 254-260

a=11.196(2)Å   b=12.653(3)Å   c=22.963(5)Å

α=104.32(3)°   β=103.24(3)°   γ=91.58(3)°

2,4 lutidine pamoate

C23H14O6,2(C7H10N)

Haynes, Delia A.Weng, Ze F.Jones, WilliamMotherwell, W. D. Samuel

CrystEngComm (2009) 11, 2 254-260

a=8.2989(17)Å   b=11.453(2)Å   c=16.924(3)Å

α=72.76(3)°   β=85.65(3)°   γ=77.85(3)°

Quinol:pyrazine

C6H6O2.C4H4N2

Oswald, Iain D. H.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 46-57

a=8.901(3)Å   b=7.666(2)Å   c=6.984(2)Å

α=90.00°   β=90.091(6)°   γ=90.00°

Quinol:piperazine

C4H10N2,C6H6O2

Oswald, Iain D. H.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 46-57

a=5.7060(15)Å   b=6.7599(19)Å   c=7.0771(18)Å

α=100.269(4)°   β=112.446(3)°   γ=90.163(3)°

Quinol:2Morpholine

2(C4H9NO)(C6H6O2)

Oswald, Iain D. H.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 46-57

a=6.6652(13)Å   b=5.5881(11)Å   c=20.034(4)Å

α=90.00°   β=94.942(4)°   γ=90.00°

Hemi-quinol pyridine adduct

C3H3O(C5H5N)

Oswald, Iain D. H.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 46-57

a=6.4990(9)Å   b=16.459(2)Å   c=7.1794(10)Å

α=90.00°   β=112.986(3)°   γ=90.00°

Quinol:2Piperidine

2(C5H11N)(C6H6O2)

Oswald, Iain D. H.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 46-57

a=10.4230(15)Å   b=5.2619(7)Å   c=15.221(2)Å

α=90.00°   β=109.920(3)°   γ=90.00°

Quinol:2(N-methylmorpholine)

2(C5H11NO)(C6H6O2)

Oswald, Iain D. H.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 46-57

a=6.9612(10)Å   b=7.3146(11)Å   c=9.659(2)Å

α=106.182(3)°   β=104.481(3)°   γ=106.201(2)°

Quinol:dimethylpiperazine

C6H14N2.C6H6O2

Oswald, Iain D. H.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 46-57

a=8.9620(8)Å   b=9.4944(8)Å   c=14.7119(13)Å

α=90.501(2)°   β=92.919(2)°   γ=99.664(2)°

C6H5F1O1

C6H5F1O1

Oswald, Iain D. H.Allan, David R.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 69-79

a=5.6510(12)Å   b=5.0642(10)Å   c=9.3185(19)Å

α=90°   β=107.518(4)°   γ=90°

C6H5F1O1

C6H5F1O1

Oswald, Iain D. H.Allan, David R.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 69-79

a=5.6747(9)Å   b=5.0760(4)Å   c=9.4753(13)Å

α=90°   β=107.832(11)°   γ=90°

C6H5Cl1O1

C6H5Cl1O1

Oswald, Iain D. H.Allan, David R.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 69-79

a=3.9846(5)Å   b=13.9272(19)Å   c=20.699(3)Å

α=90°   β=90°   γ=90°

C6H5Cl1O1

C6H5Cl1O1

Oswald, Iain D. H.Allan, David R.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 69-79

a=4.0949(4)Å   b=13.875(3)Å   c=20.716(3)Å

α=90°   β=90°   γ=90°

C6H5Cl1O1

C6H5Cl1O1

Oswald, Iain D. H.Allan, David R.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 69-79

a=8.7086(11)Å   b=15.4523(19)Å   c=8.7414(11)Å

α=90°   β=93.954(2)°   γ=90°

C6H5Cl1O1

C6H5Cl1O1

Oswald, Iain D. H.Allan, David R.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 69-79

a=3.9724(5)Å   b=12.7328(17)Å   c=23.155(3)Å

α=90°   β=94.126(2)°   γ=90°

C6H5Cl1O1

C6H5Cl1O1

Oswald, Iain D. H.Allan, David R.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 69-79

a=4.1096(4)Å   b=12.7665(10)Å   c=23.181(3)Å

α=90°   β=94.201(14)°   γ=90°

C6H5F1O1

C6H5F1O1

Oswald, Iain D. H.Allan, David R.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 69-79

a=5.7168(7)Å   b=9.9997(19)Å   c=17.868(2)Å

α=90°   β=90°   γ=90°

C6H5F1O1

C6H5F1O1

Oswald, Iain D. H.Allan, David R.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 69-79

a=17.1336(10)Å   b=8.2766(5)Å   c=11.4975(7)Å

α=90°   β=100.234(2)°   γ=90°

Paracetamol hemi-dimethylpiperazine

2[C8H9NO2][C6H14N2]

Oswald, Iain D. H.Allan, David R.McGregor, Pamela A.Motherwell, W. D. SamuelParsons, SimonPulham, Colin R.

Acta Crystallographica Section B (2002) 58, 6 1057-1066

a=10.6970(9)Å   b=11.0240(9)Å   c=9.4896(8)Å

α=90.00°   β=100.684(2)°   γ=90.00°

Paracetamol hemi(N-Methylmorpholine)

2[C8H9NO2][C5H11NO]

Oswald, Iain D. H.Allan, David R.McGregor, Pamela A.Motherwell, W. D. SamuelParsons, SimonPulham, Colin R.

Acta Crystallographica Section B (2002) 58, 6 1057-1066

a=10.5749(8)Å   b=11.0221(8)Å   c=9.3894(7)Å

α=90.00°   β=101.145(2)°   γ=90.00°

Paracetamol-bipyridine

[C8H9NO2][C10H8N2]

Oswald, Iain D. H.Allan, David R.McGregor, Pamela A.Motherwell, W. D. SamuelParsons, SimonPulham, Colin R.

Acta Crystallographica Section B (2002) 58, 6 1057-1066

a=11.2906(10)Å   b=24.103(2)Å   c=11.5526(10)Å

α=90.00°   β=96.1484(16)°   γ=90.00°

2[C8H9NO2][C4H9NO]

2[C8H9NO2][C4H9NO]

Oswald, Iain D. H.Allan, David R.McGregor, Pamela A.Motherwell, W. D. SamuelParsons, SimonPulham, Colin R.

Acta Crystallographica Section B (2002) 58, 6 1057-1066

a=7.2791(9)Å   b=14.6277(18)Å   c=18.303(2)Å

α=90.00°   β=90.00°   γ=90.00°

Paracetamol hemi-dioxane

2[C8H9O2N],[C4H8O2]

Oswald, Iain D. H.Allan, David R.McGregor, Pamela A.Motherwell, W. D. SamuelParsons, SimonPulham, Colin R.

Acta Crystallographica Section B (2002) 58, 6 1057-1066

a=12.421(5)Å   b=12.056(4)Å   c=13.396(3)Å

α=90.00°   β=91.51(3)°   γ=90.00°

2-Acetamido-4,5-dinitrotoluene

C9H9N3O5

Watkin, David J.Motherwell, W. D. S.Copper, Richard I.Pantos, Stefan

Acta Crystallographica Section E (2004) 60, 12 o2295-o2297

a=12.5693(4)Å   b=4.85310(10)Å   c=17.2663(5)Å

α=90°   β=99.1624(15)°   γ=90°

2-Acetamido-4-nitrotoluene

C9H10N2O3

Watkin, David J.Motherwell, W. D. S.Cooper, Richard I.Pantos, StefanSteadman, Oliver I.

Acta Crystallographica Section E (2005) 61, 9 o2778-o2780

a=8.2167(2)Å   b=13.6406(3)Å   c=8.7203(2)Å

α=90°   β=107.2307(9)°   γ=90°

3-Iodo-2,6-dinitrotoluene

C7H5I1N2O4

Watkin, David J.Motherwell, W. D. S.Cooper, Richard I.Pantos, StefanSteadman, Oliver I.

Acta Crystallographica Section E (2005) 61, 9 o2836-o2838

a=11.0997(5)Å   b=6.9493(3)Å   c=12.3296(5)Å

α=90°   β=92.084(2)°   γ=90°

Paracetamol--morpholine (1/2.5)

C8H9NO2,2.5C4H9NO

Oswald, Iain D. H.Motherwell, W. D. SamParsons, SimonPulham, Colin R.

Acta Crystallographica Section E (2002) 58, 11 o1290-o1292

a=8.710(4)Å   b=9.920(5)Å   c=12.385(5)Å

α=102.35(3)°   β=108.33(2)°   γ=96.68(3)°

2-(p-Nitrophenoxy)terahydropyran

C11H13NO4

Chopra, ReenuNing ShanMotherwell, W. D. SamJones, William

Acta Crystallographica Section E (2004) 60, 11 o1923-o1924

a=7.47720(10)Å   b=21.9462(4)Å   c=6.78280(10)Å

α=90.00°   β=102.4910(10)°   γ=90.00°

Indomethacin methyl ester

C20H18ClNO4

Trask, Andrew V.Shan, NingJones, WilliamMotherwell, W. D. Sam

Acta Crystallographica Section E (2004) 60, 4 o508-o509

a=19.0206(5)Å   b=4.83260(10)Å   c=19.3092(8)Å

α=90.00°   β=97.7390(10)°   γ=90.00°

Pamoic Acid

C23H16O6

Haynes, Delia A.Van de Streek, JaccoBurley, Jonathan C.Jones, WilliamMotherwell, W. D. Sam

Acta Crystallographica Section E (2006) 62, 3 o1170-o1172

a=19.7348(7)Å   b=4.78768(12)Å   c=19.2544(4)Å

α=90°   β=108.9622(17)°   γ=90°

N-(2-Methyl-3,6-dinitrophenyl)acetamide

C9H9N3O5

Watkin, David J.Motherwell, W. D. S.Cooper, Richard I.Pantos, StefanSteadman, Oliver I.

Acta Crystallographica Section E (2005) 61, 11 o3888-o3890

a=4.9309(2)Å   b=11.7571(4)Å   c=8.7944(3)Å

α=90°   β=99.8608(14)°   γ=90°

Dichloro[(η^5^-cyclopentadienyl)dimethyl(η^5^-3- phenylindenyl)silane]hafnium(IV)

C22H20Cl2Hf1Si1

Burley, Jonathan C.Motherwell, W. D. SamMaaranen, JanneRingwald, Markus

Acta Crystallographica Section E (2007) 63, 1 m238-m240

a=10.1894(4)Å   b=11.0993(4)Å   c=9.6940(4)Å

α=91.974(2)°   β=108.693(2)°   γ=80.501(3)°

3-aza-bicyclo(3.3.1)nonane-2,4-dione

C8H11N1O2

Wood, Peter A.Haynes, Delia A.Lennie, Alistair R.Motherwell, W. D. SamuelParsons, SimonPidcock, ElnaWarren, John E.

Crystal Growth & Design (2008) 8, 2 549

a=8.564(7)Å   b=10.0876(18)Å   c=7.6419(12)Å

α=90°   β=96.38(3)°   γ=90°

3-aza-bicyclo(3.3.1)nonane-2,4-dione

C8H11N1O2

Wood, Peter A.Haynes, Delia A.Lennie, Alistair R.Motherwell, W. D. SamuelParsons, SimonPidcock, ElnaWarren, John E.

Crystal Growth & Design (2008) 8, 2 549

a=9.3214(11)Å   b=10.5932(12)Å   c=7.6988(9)Å

α=90°   β=95.059(8)°   γ=90°

3-aza-bicyclo(3.3.1)nonane-2,4-dione

C8H11N1O2

Wood, Peter A.Haynes, Delia A.Lennie, Alistair R.Motherwell, W. D. SamuelParsons, SimonPidcock, ElnaWarren, John E.

Crystal Growth & Design (2008) 8, 2 549

a=8.868(9)Å   b=10.2833(16)Å   c=7.7016(13)Å

α=90°   β=95.88(3)°   γ=90°

3-aza-bicyclo(3.3.1)nonane-2,4-dione

C8H11N1O2

Wood, Peter A.Haynes, Delia A.Lennie, Alistair R.Motherwell, W. D. SamuelParsons, SimonPidcock, ElnaWarren, John E.

Crystal Growth & Design (2008) 8, 2 549

a=8.367(8)Å   b=9.9317(17)Å   c=7.5667(12)Å

α=90°   β=96.49(3)°   γ=90°

3-aza-bicyclo(3.3.1)nonane-2,4-dione

C8H11N1O2

Wood, Peter A.Haynes, Delia A.Lennie, Alistair R.Motherwell, W. D. SamuelParsons, SimonPidcock, ElnaWarren, John E.

Crystal Growth & Design (2008) 8, 2 549

a=8.254(4)Å   b=9.8542(15)Å   c=7.5245(11)Å

α=90°   β=96.63(3)°   γ=90°

3-aza-bicyclo(3.3.1)nonane-2,4-dione

C8H11N1O2

Wood, Peter A.Haynes, Delia A.Lennie, Alistair R.Motherwell, W. D. SamuelParsons, SimonPidcock, ElnaWarren, John E.

Crystal Growth & Design (2008) 8, 2 549

a=7.938(7)Å   b=9.754(3)Å   c=7.481(2)Å

α=90°   β=97.03(6)°   γ=90°

3-aza-bicyclo(3.3.1)nonane-2,4-dione

C8H11N1O2

Wood, Peter A.Haynes, Delia A.Lennie, Alistair R.Motherwell, W. D. SamuelParsons, SimonPidcock, ElnaWarren, John E.

Crystal Growth & Design (2008) 8, 2 549

a=8.054(7)Å   b=9.782(3)Å   c=7.5043(19)Å

α=90°   β=96.80(5)°   γ=90°

2.(CHBr3)2

4(C8H10N4O2)(C4H6O4)2(C1H1Br3)

Friščić, TomislavTrask, Andrew V.Motherwell, W. D. S.Jones, W.

Crystal Growth & Design (2008) 8, 5 1605

a=12.0064(4)Å   b=33.4489(8)Å   c=6.5490(2)Å

α=90.00°   β=104.9510(10)°   γ=90.00°

2.(CHCl3)2

4(C8H10N4O2),(C4H6O4),2(C1H1Cl3)

Friščić, TomislavTrask, Andrew V.Motherwell, W. D. S.Jones, W.

Crystal Growth & Design (2008) 8, 5 1605

a=6.64390(10)Å   b=23.2514(4)Å   c=33.5615(7)Å

α=90.00°   β=90.00°   γ=90.00°

C8H10N4O2,C4H4O4

C8H10N4O2,C4H4O4

Trask, Andrew V.Motherwell, W. D. SamuelJones, William

Crystal Growth & Design (2005) 5, 3 1013

a=6.8565(2)Å   b=12.5051(4)Å   c=15.8362(5)Å

α=90.00°   β=93.6100(10)°   γ=90.00°

C8H10N4O2,C5H8O4

C8H10N4O2,C5H8O4

Trask, Andrew V.Motherwell, W. D. SamuelJones, William

Crystal Growth & Design (2005) 5, 3 1013

a=13.0129(5)Å   b=6.6017(2)Å   c=17.1427(8)Å

α=90.00°   β=97.8360(10)°   γ=90.00°

C8H10N4O2,C5H8O4

C8H10N4O2,C5H8O4

Trask, Andrew V.Motherwell, W. D. SamuelJones, William

Crystal Growth & Design (2005) 5, 3 1013

a=8.3212(8)Å   b=8.6667(8)Å   c=11.3636(12)Å

α=68.955(4)°   β=78.559(4)°   γ=74.236(4)°

2(C8H10N4O2),C2H2O4

2(C8H10N4O2),C2H2O4

Trask, Andrew V.Motherwell, W. D. SamuelJones, William

Crystal Growth & Design (2005) 5, 3 1013

a=4.41430(10)Å   b=14.7701(5)Å   c=15.9119(6)Å

α=90.00°   β=96.4850(10)°   γ=90.00°

5-fluoro-2-oxindole

C8H6FNO

Day, Graeme M.Motherwell, W. D. Sam

Crystal Growth & Design (2006) 6, 9 1985

a=4.3901(3)Å   b=7.1531(5)Å   c=11.0189(8)Å

α=90.00°   β=92.880(3)°   γ=90.00°

3-quinuclidinol

C7H13N1O1

Day, Graeme M.Motherwell, W. D. Sam

Crystal Growth & Design (2006) 6, 9 1985

a=6.4549(3)Å   b=10.4034(4)Å   c=10.1283(5)Å

α=90.00°   β=92.9420(10)°   γ=90.00°

C6H12O6

C6H12O6

Day, Graeme M.van de Streek, JaccoBonnet, ArnaudBurley, Jonathan C.Jones, WilliamMotherwell, W. D. Sam

Crystal Growth & Design (2006) 6, 10 2301

a=6.7176(2)Å   b=6.7638(2)Å   c=8.6217(3)Å

α=95.3550(10)°   β=99.6860(10)°   γ=98.8790(10)°

Quinol:2(4,4'-bipyridine)

2(C10H8N2)(C6H6O2)

Oswald, Iain D. H.Motherwell, W. D. SamuelParsons, Simon

Acta Crystallographica Section B (2005) 61, 1 46-57

a=7.820(4)Å   b=8.619(4)Å   c=9.201(4)Å

α=111.897(7)°   β=109.851(7)°   γ=94.657(8)°

Paracetamol hemi-piperazine

2[C8H9NO2][C4H10N2]

Oswald, Iain D. H.Allan, David R.McGregor, Pamela A.Motherwell, W. D. SamuelParsons, SimonPulham, Colin R.

Acta Crystallographica Section B (2002) 58, 6 1057-1066

a=15.893(5)Å   b=5.1664(17)Å   c=12.993(4)Å

α=90.00°   β=113.633(5)°   γ=90.00°

2(C8H10N4O2),C3H4O4

2(C8H10N4O2),C3H4O4

Trask, Andrew V.Motherwell, W. D. SamuelJones, William

Crystal Growth & Design (2005) 5, 3 1013

a=30.3992(12)Å   b=31.2845(16)Å   c=4.6739(2)Å

α=90.00°   β=90.00°   γ=90.00°